Should you hold Nu Skin Enterprises (NUS) stock?
The consensus among Wall Street research analysts is that investors should "hold" Nu Skin Enterprises stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares. View analyst ratings for Nu Skin Enterprises or view top-rated stocks.
Is Nu Skin Enterprises’ dividend sustainable?
Nu Skin Enterprises pays a meaningful dividend of 2.98%, higher than the bottom 25% of all stocks that pay dividends. Nu Skin Enterprises has been increasing its dividend for 22 years. The dividend payout ratio of Nu Skin Enterprises is 34.31%. This payout ratio is at a healthy, sustainable level, below 75%.
Where can I buy shares of NUS?
Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Who owns Nunu Skin Enterprises'stock?
Nu Skin Enterprises' stock is owned by a number of retail and institutional investors.
Why is NUS stock down?
Shares of Nu Skin Enterprises Inc. NUS, +0.77% dropped 3.6% toward a 15-month low in premarket trading Monday, after the personal care products company warned of a revenue miss, saying the delta variant has led to unexpected COVID-related disruptions.
Is NUS stock a buy?
Analyst Price Target on NUS Based on 3 Wall Street analysts offering 12 month price targets for Nu Skin in the last 3 months. The average price target is $56.00 with a high forecast of $70.00 and a low forecast of $45.00. The average price target represents a 22.32% change from the last price of $45.78.
Should I buy or sell Nu Skin Enterprises stock right now?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 2 hold ratings a...
What is Nu Skin Enterprises' stock price forecast for 2022?
3 Wall Street research analysts have issued 12-month target prices for Nu Skin Enterprises' stock. Their forecasts range from $49.00 to $75.00. On...
How has Nu Skin Enterprises' stock performed in 2022?
Nu Skin Enterprises' stock was trading at $50.75 at the beginning of 2022. Since then, NUS stock has decreased by 10.5% and is now trading at $45.4...
Are investors shorting Nu Skin Enterprises?
Nu Skin Enterprises saw a drop in short interest in May. As of May 31st, there was short interest totaling 3,660,000 shares, a drop of 22.5% from t...
When is Nu Skin Enterprises' next earnings date?
Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022. View our earnings forecast for...
How were Nu Skin Enterprises' earnings last quarter?
Nu Skin Enterprises, Inc. (NYSE:NUS) posted its quarterly earnings data on Wednesday, May, 4th. The company reported $0.76 EPS for the quarter, bea...
How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?
Nu Skin Enterprises declared a quarterly dividend on Wednesday, May 4th. Stockholders of record on Friday, May 27th will be paid a dividend of $0.3...
Is Nu Skin Enterprises a good dividend stock?
Nu Skin Enterprises(NYSE:NUS) pays an annual dividend of $1.54 per share and currently has a dividend yield of 3.37%. Nu Skin Enterprises has been...
What guidance has Nu Skin Enterprises issued on next quarter's earnings?
Nu Skin Enterprises issued an update on its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share guidance of $3....
Nu Skin (NUS) Q4 Earnings Beat Estimates, Revenues Down
Nu Skin Enterprises (NUS) Q4 Earnings and Revenues Surpass Estimates
Nu Skin's (NUS) fourth-quarter 2021 earnings and revenues decline year over year. Management offers a drab view for the first quarter.
What happened
Nu Skin (NUS) delivered earnings and revenue surprises of 16.84% and 2.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
So what
Shares of Nu Skin Enterprises (NYSE: NUS) plunged 14.6% on Wednesday after the direct-selling personal care products company announced disappointing preliminary second-quarter 2019 results.
Now what
According to Nu Skin CEO Ritch Wood, weakness in Mainland China primarily was to blame following a 100-day campaign by the government "to review and inspect the health products and direct selling industries."
What happened
As such, Nu Skin also reduced its outlook for 2019 revenue to be in the range of $2.48 billion to $2.52 billion, which should translate to earnings per share of $3.20 to $3.35. By comparison, the company's previous guidance called for revenue of $2.76 billion to $2.81 billion, with earnings per share of $3.80 to $4.05.
So what
Shares of Nu Skin Enterprises ( NUS 0.10% ) are down 14.6% as of 1:15 p.m. EST Thursday after the personal-care consumer discretionary company announced in-line fourth-quarter 2019 results, but followed with disappointing guidance.
Now what
Quarterly revenue declined 14.6% year over year to $583.4 million, translating to net income of $40.1 million, or $0.72 per share (down from adjusted earnings of $1.05 per share in the year-ago period). Analysts, on average, were expecting roughly the same earnings on slightly lower revenue of $582 million.
Premium Investing Services
For the first quarter of 2020, Nu Skin expects revenue in the range of $480 million to $510 million, down 23% to 18% year over year, with earnings per share ranging from $0.23 to $0.33. On average, analysts were modeling earnings of $0.74 per share on revenue of $596.5 million.
What happened
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
So what
Shares of Nu Skin Enterprises ( NUS -5.56% ) plunged 14.6% on Wednesday after the direct-selling personal care products company announced disappointing preliminary second-quarter 2019 results.
Now what
According to Nu Skin CEO Ritch Wood, weakness in Mainland China primarily was to blame following a 100-day campaign by the government "to review and inspect the health products and direct selling industries."
How many points did the BSE Sensex lose?
As such, Nu Skin also reduced its outlook for 2019 revenue to be in the range of $2.48 billion to $2.52 billion, which should translate to earnings per share of $3.20 to $3.35. By comparison, the company's previous guidance called for revenue of $2.76 billion to $2.81 billion, with earnings per share of $3.80 to $4.05.
Why many first time investors may turn away from equities forever?
As the stock market resumed trade after a 45 minute halt, indices trimmed losses and the BSE Sensex was trading lower by around 700 points.Market trims losses as trade resumes, Sensex down 700 points
Did the disruption stop stocks from scaling?
Coronavirus and market crash : Why many first-time investors may turn away from equities forever. Covid-19 has eroded the wealth painstakingly built over the past 4-5 years. The bigger danger is that many first-time investors may turn away from equities forever even as a pauperised populace cuts back on consumption.